Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4106127 Target Snapshot

c-Myc/c-Max · PROTEIN-PROTEIN INTERACTION · Homo sapiens

26Compounds
12Assays
0Approved Drugs
19.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P01106. Use UniProt P01106 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P01106 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats c-Myc/c-Max as ChEMBL target CHEMBL4106127, mapped to UniProt P01106. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
c-Myc/c-Max
PROTEIN-PROTEIN INTERACTION · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4106127
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P01106
Myc proto-oncogene protein
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether c-Myc/c-Max is the right protein anchor across sources, using UniProt P01106 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMyc proto-oncogene protein
UniProt AccessionP01106
Component TypeProtein
Sequence Length454 aa

Myc proto-oncogene protein

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as c-Myc/c-Max, mapped to UniProt P01106. ChEMBL maps the protein component as Myc proto-oncogene protein. Sequence length is 454 aa.

Mapped IDP01106
Review namec-Myc/c-Max
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5017.0
EC501.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4238599 8.19 Kd 6.5 Preclinical
CHEMBL201467 5.39 IC50 4100.0 Preclinical
CHEMBL4093782 5.34 IC50 4600.0 Preclinical
CHEMBL4086023 5.19 IC50 6500.0 Preclinical
CHEMBL4103943 5.0 IC50 10000.0 Preclinical
CHEMBL4066335 4.75 IC50 18000.0 Preclinical
CHEMBL255556 4.64 IC50 23000.0 Preclinical
CHEMBL3222133 4.54 IC50 29000.0 Preclinical
CHEMBL4780968 4.54 EC50 29100.0 Preclinical
CHEMBL1336889 4.48 IC50 33000.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
0
5.5
0
6.0
0
6.5
0
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
19
Tested Compounds
1
Assay Types
Binding — 12 assays, 19 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 7 13 4.7
protein format 4 6 5.2
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine